NOVOZYMES AS/FI - COM (NVZMY)

CUSIP: 670108109

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COM
Total 13F shares
26,515
Share change
-51,453
Total reported value
$1,555,418
Price per share
$58.86
Number of holders
9
Value change
-$2,785,478
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 670108109?
CUSIP 670108109 identifies NVZMY - NOVOZYMES AS/FI - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOZYMES AS/FI - COM (NVZMY) as of Q1 2024

As of 31 Mar 2024, NOVOZYMES AS/FI - COM (NVZMY) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,515 shares. The largest 9 holders included RHUMBLINE ADVISERS, Boston Common Asset Management, LLC, MAR VISTA INVESTMENT PARTNERS LLC, S&CO INC, PNC Financial Services Group, Inc., WETZEL INVESTMENT ADVISORS, INC., GAMMA Investing LLC, Operose Advisors LLC, and Financial Avengers, Inc.. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.